BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $9,376,000 | -3.0% | 8,667,000 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $9,669,000 | +2.4% | 8,667,000 | +1.8% | 0.00% | +33.3% |
| Q2 2017 | $9,438,000 | -1.9% | 8,517,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $9,619,000 | +1.0% | 8,517,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $9,523,000 | -6.8% | 8,517,000 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $10,215,000 | +8.0% | 8,517,000 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $9,459,000 | -4.1% | 8,517,000 | 0.0% | 0.00% | -25.0% |
| Q1 2016 | $9,864,000 | -9.8% | 8,517,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $10,934,000 | -32.4% | 8,517,000 | -32.0% | 0.00% | -42.9% |
| Q3 2015 | $16,170,000 | -16.2% | 12,517,000 | 0.0% | 0.01% | -12.5% |
| Q2 2015 | $19,292,000 | +3.6% | 12,517,000 | 0.0% | 0.01% | +14.3% |
| Q1 2015 | $18,627,000 | +26.6% | 12,517,000 | 0.0% | 0.01% | +16.7% |
| Q4 2014 | $14,715,000 | +7.9% | 12,517,000 | -2.8% | 0.01% | +20.0% |
| Q3 2014 | $13,637,000 | +28.6% | 12,880,000 | +25.7% | 0.01% | +25.0% |
| Q2 2014 | $10,602,000 | +4.6% | 10,250,000 | +10.8% | 0.00% | 0.0% |
| Q1 2014 | $10,135,000 | +3.4% | 9,250,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $9,799,000 | – | 9,250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|